http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23458809

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1178
issn 0027-8874
1460-2105
issueIdentifier 16
pageRange 1167-1178
publicationName JNCI Journal of the National Cancer Institute
startingPage 1167
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
bibliographicCitation Ottewell PD, Monkkonen H, Jones M, Lefley DV, Coleman RE, Holen I. Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer. JNCI Journal of the National Cancer Institute. 2008 Aug 11;100(16):1167–78. doi: 10.1093/jnci/djn240.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47b131b87e45c9f176b59a8f070c3dfb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4eeadc66c3d1d409c86a0a56639c275e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ecb21f9724ca6b2f948196621e12f47
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c1d2970bfcf1f8d6ca5baf05e36792f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43c653202d4fb856453ae433d60c0f81
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b8195adab9e10afefe63c5ea60b6d59
date 2008-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1093/jnci/djn240
https://pubmed.ncbi.nlm.nih.gov/18695136
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4982
https://portal.issn.org/resource/ISSN/1460-2105
https://portal.issn.org/resource/ISSN/0027-8874
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
discusses http://id.nlm.nih.gov/mesh/M0239778
http://id.nlm.nih.gov/mesh/M0001348
http://id.nlm.nih.gov/mesh/M0028859
http://id.nlm.nih.gov/mesh/M0472480
http://id.nlm.nih.gov/mesh/M0006519
http://id.nlm.nih.gov/mesh/M0234600
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008325Q000188
http://id.nlm.nih.gov/mesh/D007093Q000494
http://id.nlm.nih.gov/mesh/D004164Q000494
http://id.nlm.nih.gov/mesh/D004317Q000494
http://id.nlm.nih.gov/mesh/D000971Q000494
http://id.nlm.nih.gov/mesh/D000903Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004164Q000008
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D004195
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008325Q000473
http://id.nlm.nih.gov/mesh/D012107
http://id.nlm.nih.gov/mesh/D007093Q000008
http://id.nlm.nih.gov/mesh/D004357
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D014057
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D020411
http://id.nlm.nih.gov/mesh/D053148Q000032
http://id.nlm.nih.gov/mesh/D004317Q000008
http://id.nlm.nih.gov/mesh/D000077211
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D050071Q000494
http://id.nlm.nih.gov/mesh/D007150
http://id.nlm.nih.gov/mesh/D019394Q000032
http://id.nlm.nih.gov/mesh/D000903Q000008
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D016133
http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3b7b548dc433c7399ca3cf61af618a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7073
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7e27445665b52785b921da1d7b6d5b45

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788750

Total number of triples: 78.